Unknown

Dataset Information

0

Comparative efficacy of intravenous immunoglobulin and protein A immunoadsorption in severe anti-NMDAR encephalitis

ABSTRACT:

SUBMITTER: Tang X 

PROVIDER: S-EPMC12378923 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.
| S-EPMC9082384 | biostudies-literature
Unknown Short delay to initiate plasma exchange or immunoadsorption as synergistic therapies for patients in the acute phase of anti-NMDAR encephalitis.
| S-EPMC11561987 | biostudies-literature
Unknown Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.
| S-EPMC11937155 | biostudies-literature
Unknown The Chinese experience with anti-NMDAR encephalitis.
| S-EPMC7327338 | biostudies-literature
Unknown Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis.
| S-EPMC8529218 | biostudies-literature
Unknown Intravenous immunoglobulin for the treatment of childhood encephalitis.
| S-EPMC6485509 | biostudies-literature
Unknown CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis.
| S-EPMC4630685 | biostudies-literature
Unknown Safety and Efficacy of a Neonatal Fc Receptor Antagonist in Patients With Anti‐NMDAR Encephalitis
| S-EPMC12336417 | biostudies-literature
Unknown Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis.
| S-EPMC11921143 | biostudies-literature
Unknown Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
| S-EPMC7106675 | biostudies-literature